Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Mild Relapsing Wegener's Granulomatosis
NCT00468208Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Feb 2008
- Primary completion
- Aug 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of abatacept in granulomatosis with polyangiitis (GPA), sponsored by University of Pennsylvania. Primary endpoint: Number of Participants With Adverse Events. Started Feb 2008; status: completed.
02
Drugs
abatacept
03
Conditions
granulomatosis with polyangiitis (GPA)
Beyond the preview
Go deeper on NCT00468208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00468208.